Skeletal effects of adjuvant zoledronic acid and its cessation in women with early-stage breast cancer

被引：0
|
作者：
Ramchand, Sabashini K. [1 ,2 ]
机构：
[1] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Endocrinol & Metab Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Austin Hlth, Dept Med, 145 Studley Rd, Melbourne, VIC 3084, Australia
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2024年 / 39卷 / 09期
关键词：
PATHOGENESIS; MECHANISMS; FRACTURES; THERAPY;
D O I：
10.1093/jbmr/zjae120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1203 / 1204
页数：2
相关论文
共 50 条
  • [1] Zoledronic acid in early-stage breast cancer
    Normanno, Nicola
    De Luca, Antonella
    Gallo, Marianna
    Lamura, Luana
    Perrone, Francesco
    [J]. LANCET ONCOLOGY, 2011, 12 (11): : 991 - 991
  • [2] Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer
    Chacko, Geena
    Kota, Srigowri
    Kumar, Shicha
    Ohri, Nisha
    Omene, Coral
    Ganesan, Shridar
    Toppmeyer, Deborah L.
    George, Mridula A.
    [J]. ANTI-CANCER DRUGS, 2023, 34 (04) : 592 - 594
  • [3] Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer
    Hershman, Dawn L.
    McMahon, Donald J.
    Crew, Katherine D.
    Cremers, Serge
    Irani, Dinaz
    Cucchiara, Gina
    Brafman, Lois
    Shane, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4739 - 4745
  • [4] Zoledronic acid ameliorates the effects of endocrine therapy on bone health in women with early-stage breast cancer
    Coleman, Robert E.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2009, 5 (02): : 72 - 73
  • [5] Zoledronic acid ameliorates the effects of endocrine therapy on bone health in women with early-stage breast cancer
    Robert E Coleman
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2009, 5 : 72 - 73
  • [6] Should adjuvant zoledronic acid be used in early-stage, endocrine-sensitive breast cancer?
    Lamond, N. W. D.
    Skedgel, C.
    Rayson, D.
    Younis, T.
    [J]. CANCER RESEARCH, 2013, 73
  • [7] Should adjuvant zoledronic acid be used in early-stage, endocrine-sensitive breast cancer?
    Lamond, Nathan William Dana
    Skedgel, Chris
    Rayson, Daniel
    Younis, Tallal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Routine Use of Zoledronic Acid in Early-Stage Breast Cancer
    Harnden, Kathleen
    Blackwell, Kimberly
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (04): : 480 - 486
  • [9] Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer
    Sugie, Tomoharu
    Suzuki, Eiji
    Yamauchi, Akira
    Yamagami, Kazuhiko
    Masuda, Norikazu
    Gondo, Naomi
    Sumi, Eriko
    Ikeda, Takafumi
    Tada, Harue
    Uozumi, Ryuji
    Kanao, Shotaro
    Tanaka, Yoshimasa
    Hamazaki, Yoko
    Minato, Nagahiro
    Toi, Masakazu
    [J]. BREAST, 2018, 38 : 114 - 119
  • [10] Zoledronic acid reduces recurrence in women with early-stage breast cancer undergoing hormonal therapy
    不详
    [J]. ONCOLOGY-NEW YORK, 2008, 22 (07): : 805 - +
12345